GlassScriptPhysician profile
Abdullah Alfawaz
NPI 1922357243
$9,700.39
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,475 · 2020: $1,226.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,644.77 | 2019-2020 | |
| Silk Road Medical, INC. | $1,106.95 | 2019 | |
| Abbott Laboratories | $925.25 | 2019-2020 | |
| Cook Medical LLC | $547.10 | 2019-2020 | |
| Boston Scientific Corporation | $367.72 | 2019-2020 | |
| Cook Incorporated | $363.35 | 2019 | |
| Inari Medical, INC. | $310.22 | 2020 | |
| Penumbra, INC. | $238.31 | 2019-2020 | |
| Smith+Nephew, INC. | $74.98 | 2020 | |
| Philips North America LLC | $40.90 | 2019 | |
| Tactile Systems Technology INC | $32.22 | 2020 | |
| Cardiovascular Systems INC. | $23.45 | 2020 | |
| Bard Peripheral Vascular, INC. | $16.36 | 2020 | |
| Artivion, INC. | $8.81 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Alfawaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.